FEATURED BLOG

Why Cloudbyz CTMS is the Best Choice for Biotechnology Companies

For biotechnology companies looking to streamline their clinical trial management, reduce time to market, and achieve better outcomes, Cloudbyz CTMS is the solution that delivers. Its specialized features, scalability, and commitment to innovation make it the best choice for managing the complexities of biotechnology clinical trials today and in the future.

View Story

Why Cloudbyz CTMS is the Best Choice for Biotechnology Companies

For biotechnology companies looking to streamline their clinical trial management, reduce time to market, and achieve better outcomes, Cloudbyz CTMS is the solution that delivers. Its specialized features, scalability, and commitment to innovation make it the best choice for managing the complexities of biotechnology clinical trials today and in the future.

View Story

FEATURED BLOG

September 25, 2020 by Ani Mayasandra

We analyzed 164 pharmacovigilance startups impacting the industry. HEPAprint, MEDIKURA, Navro, Embleema & Cloudbyz develop 5 top solutions to watch out for. Learn more in our Global Startup Heat Map!

Categories

All

Blog > Clinical Services

How AI Can Enhance Clinical Data Management

Cloudbyz EDC is a powerful tool that enhances the quality, compliance, and efficiency of clinical trials. Its user-friendly interfaces, robust collaboration features, and comprehensive data security measures make it an ideal choice for organizations seeking to streamline their clinical research processes. By leveraging Cloudbyz EDC, researchers can ensure that their data is accurate, compliant, and secure, ultimately contributing to the success of their clinical trials.

Mergers in Pharma and Biotech: Shaping the Future of Clinical Trials Technology

The wave of mergers and acquisitions in the pharmaceutical and biotech sectors is reshaping the clinical trials landscape, driving substantial investments in advanced management technologies. These investments are crucial in addressing the complexities of modern clinical trials, enhancing efficiency, ensuring regulatory compliance, and ultimately accelerating the development of life-saving therapies.

Understanding Electronic Data Capture (EDC) in Clinical Research

Electronic Data Capture systems are transforming the way clinical trials are conducted, offering significant improvements in data accuracy, management, and compliance. By carefully evaluating the key capabilities and choosing a reliable provider, organizations can leverage EDC systems to enhance the efficiency and success of their clinical research efforts. EDC is not just a technological advancement; it is a critical component of modern clinical trials that drives better outcomes and fosters innovation in medical research.

25 Reasons Why Pharmaceutical Companies Need a Unified Clinical Trial Management Platform Built on Salesforce

A unified clinical trial management platform built on Salesforce offers a versatile and powerful solution for pharmaceutical companies. With its scalability, regulatory compliance, and robust features, Salesforce empowers organizations to streamline their clinical trial operations, reduce costs, and accelerate drug development. By embracing this platform, pharmaceutical companies can not only enhance their efficiency but also contribute to the timely delivery of life-saving medications to patients worldwide.

Investigator Initiated Trials (IIT), Investigator Initiated Research (IIR), and Grants Management: Digitization with Salesforce Experience Cloud

Investigator Initiated Trials (IIT), Investigator Initiated Research (IIR), and Grants Management are vital components of advancing medical research. Salesforce Experience Cloud offers a comprehensive solution for digitizing and streamlining these processes, ensuring efficient management, compliance, and collaboration among stakeholders. By harnessing the power of Salesforce Experience Cloud, research institutions can accelerate the pace of discovery and make a meaningful impact on patient care and scientific knowledge.

Challenges of managing PHI & PII Data in Life Sciences and How AI/ML can help

The challenge of managing and securing sensitive data in life sciences organizations is significant and growing. However, AI/ML-based PHI and PII solutions offer a promising solution to these challenges, helping organizations protect sensitive data, comply with data protection regulations, and improve efficiency and accuracy.

Investigator-Initiated Trials Project Development: Critical Questions

Investigator-initiated trials are a valuable avenue for advancing medical knowledge and improving patient care. By addressing these critical questions during the project development phase, you can increase the likelihood of success and contribute to the growth of clinical research. Remember that collaboration, meticulous planning, and a commitment to ethical research are essential elements of a successful IIT project.

Navigating the Path to Clinical Trials: A Guide to Grants Management for Investigators

Grants management is a critical aspect of running successful clinical trials as an investigator. Securing funding, adhering to compliance requirements, and effectively managing resources are key components of this process. By understanding and mastering the art of grants management, investigators can bring their innovative clinical trial ideas to fruition, contributing to advancements in medical science and patient care.

Accelerating Pharmaceutical Drug Market Access: The Role of Investigator-Initiated Trials and Digital Platforms

Investigator-Initiated Trials hold immense potential in advancing pharmaceutical drug development, but they also present significant challenges. Digital platforms and technologies are becoming indispensable tools in overcoming these challenges by streamlining trial management, enhancing collaboration, and accelerating the path to market access for innovative therapies. As the pharmaceutical industry continues to evolve, the integration of digital solutions will play an increasingly critical role in bringing new treatments to patients in need.